GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation

Male 0301 basic medicine bone marrow QH301-705.5 Science Blotting, Western Smad7 Protein Mice 03 medical and health sciences GAS5 Animals Humans Biology (General) In Situ Hybridization, Fluorescence stromal cells Electrophoresis, Agar Gel 0303 health sciences Osteoblasts Q R Cell Differentiation Cell Biology osteoporosis Mice, Inbred C57BL 13. Climate action osteoblast differentiation Trans-Activators Medicine Osteoporosis Female RNA, Long Noncoding RNA Helicases
DOI: 10.7554/elife.59079 Publication Date: 2020-10-02T12:00:17Z
ABSTRACT
Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. It is still necessary to explore its detailed mechanisms and identify novel targets for the treatment of osteoporosis. Previously, we found that a lncRNA named GAS5 in human could negatively regulate the lipoblast/adipocyte differentiation. However, it is still unclear whether GAS5 affects osteoblast differentiation and whether GAS5 is associated with osteoporosis. Our current research found that GAS5 was decreased in the bones and BMSCs, a major origin of osteoblast, of osteoporosis patients. Mechanistically, GAS5 promotes the osteoblast differentiation by interacting with UPF1 to degrade SMAD7 mRNA. Moreover, a decreased bone mass and impaired bone repair ability were observed in Gas5 heterozygous mice, manifesting in osteoporosis. The systemic supplement of Gas5-overexpressing adenoviruses significantly ameliorated bone loss in an osteoporosis mouse model. In conclusion, GAS5 promotes osteoblast differentiation by targeting the UPF1/SMAD7 axis and protects against osteoporosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....